Lipoprotein-regulating medicaments
US6946444B2 · kind B2 · utility
9Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2002 |
| Grant date | Sep 20, 2005 |
| Priority date | — |
| Expiry date | Jul 17, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions useful for modulating lipoprotein levels in vivo. The invention stems from the discovery that activity of the Lipolysis Stimulated Receptor (LSR) can be inhibited or enhanced by exogenous agents, including polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.